Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway
J. Clin. Invest. Igor Matushansky, et al. 117:3248 doi:10.1172/JCI31377 [Go to this article.]

Figure 3
Wnt signaling in hMSCs. (A) Expression of Wnt2 and Wnt5a by RT-PCR in the indicated sarcomas. (B) Immunoblot analysis of Wnt2 and Wnt5a in the indicated samples. (C) ELISA of β-catenin in the indicated samples following specified treatments.